Hormonal monitoring of ovarian activity using the Ovarian Monitor, Part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay

Steroids

Volumn 68, Issue 5, 2003, Pages 465-476

  Blackwell, Leonard F ^a   Brown, James B ^b   Vigil, Pilar ^c   Gross, Barbara ^d   Sufi, Saulat ^e   D'Arcangues, Catherine ^f  

^a MASSEY UNIVERSITY   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d WESTMEAD HOSPITAL   (Australia)

^e WHO London Laboratory   (United Kingdom)

^f WORLD BANK   (United States)

Author keywords

Home Ovarian Monitor; Identification of phases of fertility and infertility; Natural regulation of fertility; Ovulatory cycle; Pregnanediol glucuronide; Radioimmunoassay; Steroid; Urinary estrone glucuronide

Indexed keywords

ESTRONE GLUCURONIDE; PREGNANEDIOL;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CORRELATION COEFFICIENT; FEMALE; HEALTH CENTER; HOME; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; LABORATORY TEST; MENSTRUAL CYCLE; NORMAL HUMAN; OVARY FUNCTION; OVULATION; RADIOIMMUNOASSAY; UNITED KINGDOM; URINALYSIS; URINARY EXCRETION; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

EID: 0037530353     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(03)00049-7     Document Type: Article

References (21)

1. Brown J.B., Blackwell L.F., Cox R.I., Holmes J.M., Smith M.A. Chemical and homogeneous enzyme immunoassay methods for the measurement of estrogens and pregnanediol and their glucuronides in urine. Prog. Clin. Biol. Res. 285:1988;119-138.
2. Conway B. Evaluation of a home test kit for the measurement of urinary pregnanediol-3-glucuronide for application to natural family planning. Melbourne: Monash University; 1986. p. 44.
3. Behre H.M., Kuhlage J., Gassner C., Sonntag B., Schem C., Schneider H.P.et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum. Reprod. 15(12):2000;2478-2482.
4. Brown J.B., Holmes J., Barker G. Use of the Home Ovarian Monitor in pregnancy avoidance. Am. J. Obstet. Gynecol. 165(6 Pt 2):1991;2008-2011.
5. Brown J.B., Blackwell L.F., Holmes J., Smyth K. New assays for identifying the fertile period. Int. J. Gynecol. Obstet. Suppl. 1:1989;111-122.
6. Thornton S.J., Pepperell R.J., Brown J.B. Home monitoring of gonadotropin ovulation induction using the Ovarian Monitor. Fertil. Steril. 54(6):1990;1076-1082.
7. Cavero C. Using an Ovarian Monitor as an adjunct to natural family planning. J. Nurse Midwifery. 40(3):1995;269-276.
8. Brown J.B., Bulbrook R.D., Greenwood F.C. An evaluation of a chemical method for the estimation of oestriol, oestrone and oestradiol-17β in human urine. J. Endocrinol. 16:1957;41-48.
9. Sufi S, Ahsan R, Crocombe KJ, Shapton RA. Laboratory method manual for radioimmunoassay of pregnanediol-3α-glucuronide and estrone-3-glucuronide. 1st ed. London; 1988. p. 15-22.
10. Rubenstein K., Schneider R., Ullman E. Homogeneous enzyme immunoassay. Biochem. Biophys. Res. Commun. 47:1972;846-851.
11. Kellie A. The radioimmunoassay of steroid glucuronides. J. Steroid Biochem. 6:1975;227-281.
12. Erlanger B.F., Borek F., Beiser S.M., Lieberman S. Steroid-protein conjugates. 1. Preparation and characterisation of conjugates of bovine serum albumin with testosterone and with cortisone. J. Biol. Chem. 234:1957;713-727.
13. Brown JB, Blackwell LF. The Ovarian Monitor instruction manual. Canberra: National Library of Australia; 1989. p. 1-37.
14. Blackwell L.F., Brown J.B. Application of time-series analysis for the recognition of increases in urinary estrogens as markers for the beginning of the potentially fertile period. Steroids. 57(11):1992;554-562.
15. Blackwell L.F., Brown J.B., Cooke D.G. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle. Steroids. 63:1998;5-13.
16. Deming WE. Statistical adjustment of data. New York: John Wiley and Sons; 1943. p. 184.
17. Brown J.B. The metabolism of oestrogens and the measurement of the excretory products in urine. J. Obstet. Gynaecol. Br. Empire. 66:1959;795-803.
18. Brown J, Harrisson P, Smith M, Burger H. Correlations between the mucus symptoms and the hormonal markers of fertility throughout reproductive life. Advocate Press; 1981.
19. Barrett S.A., Brown J.B. An evaluation of the method of Cox for the rapid analysis of pregnanediol in urine by gas-liquid chromatography. J. Endocrinol. 47(4):1970;471-480.
20. Kennedy K.I., Gross B.A., Parenteau-Carreau S., Flynn A.M., Brown J.B., Visness C.M. Breastfeeding and the symptothermal method. Stud. Family Plan. 26(2):1995;107-115.
21. Adlercreutz H., Brown J., Collins W., Goebelsman U., Kellie A., Campbell H.et al. The measurement of urinary steroid glucuronides as indices of the fertile period in women. J. Steroid Biochem. 17(6):1982;695-702.